Safety and effectiveness of mepolizumab in adult patients with severe asthma with an eosinophilic phenotype from India: a Phase IV, open-label, single-arm, 24-week study (PRISM).
- DOI
- 10.1080/02770903.2025.2475452
- Published
- 2025 Aug
- Container
- The Journal of asthma : official journal of the Association for the Care of Asthma
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/02770903.2025.2475452,
title = {Safety and effectiveness of mepolizumab in adult patients with severe asthma with an eosinophilic phenotype from India: a Phase IV, open-label, single-arm, 24-week study (PRISM).},
author = {Meshram P and Maturu VN and Swarnakar R and Deb P and Gupta D and Adsule S and Hegde R},
year = {2025},
journal = {The Journal of asthma : official journal of the Association for the Care of Asthma},
doi = {10.1080/02770903.2025.2475452},
url = {https://doi.org/10.1080/02770903.2025.2475452}
}RIS
TY - JOUR TI - Safety and effectiveness of mepolizumab in adult patients with severe asthma with an eosinophilic phenotype from India: a Phase IV, open-label, single-arm, 24-week study (PRISM). AU - Meshram P AU - Maturu VN AU - Swarnakar R AU - Deb P AU - Gupta D AU - Adsule S AU - Hegde R PY - 2025 JO - The Journal of asthma : official journal of the Association for the Care of Asthma DO - 10.1080/02770903.2025.2475452 UR - https://doi.org/10.1080/02770903.2025.2475452 ER -
APA
P, M., VN, M., R, S., P, D., D, G., S, A., & R, H. (2025). Safety and effectiveness of mepolizumab in adult patients with severe asthma with an eosinophilic phenotype from India: a Phase IV, open-label, single-arm, 24-week study (PRISM).. The Journal of asthma : official journal of the Association for the Care of Asthma. https://doi.org/10.1080/02770903.2025.2475452
Source records
- pubmed · retrieved 2026-09-26T08:37:32.293Z